Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $460.7300 (-2.07%) ($460.7300 - $460.7300) on Mon. Feb. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.61% (three month average) | RSI | 15 | Latest Price | $460.7300(-2.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1% a day on average for past five trading days. | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(43%) DIA(37%) SPLV(37%) IVW(36%) | Factors Impacting REGN price | REGN will decline at least -0.805% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.805% (StdDev 1.61%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $495.53 | 5 Day Moving Average | $474.03(-2.81%) | 10 Day Moving Average | $481.46(-4.31%) | 20 Day Moving Average | $495.53(-7.02%) | To recent high | -16.1% | To recent low | 0% | Market Cap | $48.851b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |